In this special event, learn of the processes that healthcare companies need to follow to attain approvals and how the trial phases work. In addition, gain valuable insights on whats moving the sector, as well as some of the most notable entities within the space.
Join guest speakers from ASX healthcare companies, including:
- Recce Pharmaceuticals (ASX:RCE): Chief Scientific Officer, Michele Dilizia
- BlinkLab (ASX:BB1): Chairman, Brian Leedman
- Race Oncology (ASX:RAC): CEO, Daniel Tillett
- Bioshares: Editor, Mark Pachacz
Attendees will also have the opportunity to take part in a liveQ+A with panel participants.
[WEBINAR] What it takes to get a new drug to market in Australia
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RCE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
48.0¢ |
Change
-0.010(2.04%) |
Mkt cap ! $98.93M | |||
| Open | High | Low | Value | Volume |
| 49.5¢ | 49.5¢ | 48.0¢ | $114.6K | 237.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 22510 | 47.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 48.5¢ | 98698 | 2 |
View Market Depth
| Last trade - 15.37pm 03/07/2024 (20 minute delay) ? |
| RCE (ASX) Chart |